Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 21;47(1):13.
doi: 10.1186/s13052-021-00954-4.

Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus

Carlo Fusco  1 , Vincenzo Leuzzi  2 , Pasquale Striano  3   4 , Roberta Battini  5   6 , Alberto Burlina  7 ; Delphi panel experts’ group; Carlotta Spagnoli  8
Collaborators, Affiliations

Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus

Carlo Fusco et al. Ital J Pediatr. .

Abstract

Background: Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare and underdiagnosed neurometabolic disorder resulting in a complex neurological and non-neurological phenotype, posing diagnostic challenges resulting in diagnostic delay. Due to the low number of patients, gathering high-quality scientific evidence on diagnosis and treatment is difficult. Additionally, based on the estimated prevalence, the number of undiagnosed patients is likely to be high.

Methods: Italian experts in AADC deficiency formed a steering committee to engage clinicians in a modified Delphi consensus to promote discussion, and support research, dissemination and awareness on this disorder. Five experts in the field elaborated six main topics, each subdivided into 4 statements and invited 13 clinicians to give their anonymous feedback.

Results: 100% of the statements were answered and a consensus was reached at the first round. This enabled the steering committee to acknowledge high rates of agreement between experts on clinical presentation, phenotypes, diagnostic work-up and treatment strategies. A research gap was identified in the lack of standardized cognitive and motor outcome data. The need for setting up an Italian working group and a patients' association, together with the dissemination of knowledge inside and outside scientific societies in multiple medical disciplines were recognized as critical lines of intervention.

Conclusions: The panel expressed consensus with high rates of agreement on a series of statements paving the way to disseminate clear messages concerning disease presentation, diagnosis and treatment and strategic interventions to disseminate knowledge at different levels. Future lines of research were also identified.

Keywords: AADC deficiency; Aromatic L-amino acid decarboxylase deficiency; Delphi consensus; Delphi method; Metabolic disease; Neurometabolic disorder.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Fow-chart representing the process leading to finalization of recommendations
See this image and copyright information in PMC

References

    1. Hyland K, Clayton PT. Aromatic amino acid decarboxylase deficiency in twins. J Inherit Metab Dis. 1990;13(3):301–304. doi: 10.1007/BF01799380. - DOI - PubMed
    1. Pearson TS, Gilbert L, Opladen T, Garcia-Cazorla A, Mastrangelo M, Leuzzi V, Tay SK, Sykut-Cegielska J, Pons R, Mercimek-Andrews S, Kato M, Lücke T, Oppebøen M, Kurian M, Steel D, Manti F, Meeks KD, Jeltsch K, Flint L. AADC deficiency from infancy to adulthood: symptoms and developmental outcome in an international cohort of 63 patients. J Inherit Metab Dis 2020. doi: 10.1002/jimd.12247. Epub ahead of print. - PMC - PubMed
    1. Whitehead N, Schu M, Erickson SW, Croxford J, Peters M, Hyland K. Estimated prevalence of aromatic l-amino acid decarboxylase (AADC) deficiency in the United States, European Union, and Japan [poster], Annual Congress of the European Society for gene and Cell Therapy. Lausanne; 2018.
    1. Hyland K, Reott M. Prevalence of aromatic l-amino acid decarboxylase deficiency in at-risk populations. Pediatr Neurol. 2020;106:38–42. doi: 10.1016/j.pediatrneurol.2019.11.022. - DOI - PubMed
    1. Pons R, Ford B, Chiriboga CA, Clayton PT, Hinton V, Hyland K, Sharma R, De Vivo DC. Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis. Neurology. 2004;62(7):1058–1065. doi: 10.1212/WNL.62.7.1058. - DOI - PubMed

Publication types

Substances

Supplementary concepts